256 related articles for article (PubMed ID: 20563710)
21. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.
Ku CC; Padilla JA; Grose C; Butcher EC; Arvin AM
J Virol; 2002 Nov; 76(22):11425-33. PubMed ID: 12388703
[TBL] [Abstract][Full Text] [Related]
22. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
Choi EJ; Lee CH; Shin OS
Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
[TBL] [Abstract][Full Text] [Related]
23. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
24. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells.
Sen N; Arvin AM
J Virol; 2016 Jan; 90(7):3284-7. PubMed ID: 26792747
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
Arvin AM; Koropchak CM
J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use.
Nikkels AF; Debrus S; Sadzot-Delvaux C; Piette J; Rentier B; Piérard GE
J Med Virol; 1995 Dec; 47(4):342-7. PubMed ID: 8636701
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
29. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
Weigle KA; Grose C
J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
Steain M; Gowrishankar K; Rodriguez M; Slobedman B; Abendroth A
J Virol; 2011 Jan; 85(1):626-31. PubMed ID: 20980518
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
[TBL] [Abstract][Full Text] [Related]
32. Varicella-zoster virus infection of a human CD4-positive T-cell line.
Zerboni L; Sommer M; Ware CF; Arvin AM
Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
Brunell PA; Novelli VM; Keller PM; Ellis RW
J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
[TBL] [Abstract][Full Text] [Related]
34. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
35. Evidence of latent varicella-zoster virus in rat dorsal root ganglia.
Annunziato P; LaRussa P; Lee P; Steinberg S; Lungu O; Gershon AA; Silverstein S
J Infect Dis; 1998 Nov; 178 Suppl 1():S48-51. PubMed ID: 9852973
[TBL] [Abstract][Full Text] [Related]
36. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
[TBL] [Abstract][Full Text] [Related]
37. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
38. Varicella virus-mononuclear cell interaction.
White TM; Gilden DH
Adv Virus Res; 2003; 62():1-17. PubMed ID: 14719363
[TBL] [Abstract][Full Text] [Related]
39. RNA Polymerase III as a Gatekeeper to Prevent Severe VZV Infections.
Carter-Timofte ME; Paludan SR; Mogensen TH
Trends Mol Med; 2018 Oct; 24(10):904-915. PubMed ID: 30115567
[TBL] [Abstract][Full Text] [Related]
40. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
